2019
DOI: 10.1007/s11136-019-02320-8
|View full text |Cite
|
Sign up to set email alerts
|

Capturing the patient voice: implementing patient-reported outcomes across the health system

Abstract: Purpose Supporting the capture and use of patient-reported outcomes (PROs) at the point-of-care enriches information about important clinical and quality of life outcomes. Yet the ability to scale PROs across healthcare systems has been limited by knowledge gaps around how to manage the diversity of PRO uses and leverage health information technology. In this study, we report learnings and practice insights from UW Medicine's practice transformation efforts to incorporate patient voice into multiple areas of c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
48
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 48 publications
(48 citation statements)
references
References 31 publications
0
48
0
Order By: Relevance
“…Patient-reported outcomes (PROs) are the gold standard of evaluating the impact of cancer and its treatment from the patient's perspective. The importance of PROs is reflected in their widespread use as study endpoints in cancer clinical trials [1,2] and in the steadily increasing integration of routine PRO assessments in daily clinical practice [3,4]. Regulatory authorities such as the United States Food and Drug Administration [5] and the European Medicines Agency [6] have published guidance documents to foster the collection of high-quality PRO data in clinical trials.…”
Section: Introductionmentioning
confidence: 99%
“…Patient-reported outcomes (PROs) are the gold standard of evaluating the impact of cancer and its treatment from the patient's perspective. The importance of PROs is reflected in their widespread use as study endpoints in cancer clinical trials [1,2] and in the steadily increasing integration of routine PRO assessments in daily clinical practice [3,4]. Regulatory authorities such as the United States Food and Drug Administration [5] and the European Medicines Agency [6] have published guidance documents to foster the collection of high-quality PRO data in clinical trials.…”
Section: Introductionmentioning
confidence: 99%
“…The aim of the proposed MMSR using narrative synthesis is to address an existing gap about the needs, capabilities, motivations, and individual factors influencing HCPs adoption behavior (i.e., integration of individual-level PCM data into daily practice for decision-making and care planning). The evidence on implementing PCM focuses predominantly on the CFIR domains about the intervention characteristics (e.g., [ 7 , 61 , 64 ]), inner setting, and implementation process [ 63 ]. To date, no single review captures the voice of end-users.…”
Section: Discussionmentioning
confidence: 99%
“…Thus adverse events reported on clinical trials may not be generalizable to patients receiving the same treatment as standard of care. In contrast, PROs give a voice to patients 13,14 . Without PRO data from high‐quality studies, 6 patients instead may rely on anecdotal information from the internet about what to expect for a given disease and treatment 15 .…”
Section: The Need For Pghd In Cancer Carementioning
confidence: 99%
“…These initial concerns commonly focus on the time required to collect and address PROs in the clinic, lack of training regarding the interpretation and management of some PROs, patient burden, and liability issues if PROs are overlooked 231‐233 . Thus an important aspect of the successful clinical implementation of PROs is addressing provider concerns, including appropriate provider training and clinical decision support 13,14,18,234,235 . Concerns may also be ameliorated in part by communicating observed benefits of PROs reported by other providers.…”
Section: Challenges and Opportunities For Clinical Integration Of Pghdmentioning
confidence: 99%